SCHEMBL17479147

SCHEMBL17479147

Cc1cc(O)nc2ccc(NC(=O)c3cc(CN4CCOCC4)cnc3N3CCC(C(N)=O)C3)cc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 8/20 0.44
MAPT P10636 7/20 0.43
KDM4E B2RXH2 4/20 0.43
HSD17B10 Q99714 4/20 0.43
ALDH1A1 P00352 3/20 0.43
HPGD P15428 2/20 0.43
GLA P06280 3/20 0.42
GAA P10253 3/20 0.41
ACKR3 P25106 1/20 0.41
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TP53 P04637 2/20 0.39
MAPK1 P28482 2/20 0.39
MELK Q14680 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17479041 0.94 GBA1 (0.45) GBA1MAPTKDM4EHSD17B10ALDH1A1
SCHEMBL17478973 0.91 MAPT (0.47) GBA1MAPTKDM4EHSD17B10ALDH1A1
SCHEMBL17478641 0.91 GBA1 (0.44) GBA1MAPTKDM4EHSD17B10ALDH1A1
SCHEMBL17478707 0.91 GBA1 (0.44) GBA1MAPTKDM4EHSD17B10ALDH1A1
SCHEMBL17479757 0.90 GBA1 (0.43) GBA1MAPTKDM4EHSD17B10ALDH1A1
SCHEMBL17478822 0.89 GBA1 (0.43) GBA1MAPTKDM4EHSD17B10ALDH1A1
SCHEMBL17479305 0.89 GBA1 (0.43) GBA1MAPTKDM4EHSD17B10ALDH1A1
SCHEMBL17478811 0.89 GBA1 (0.50) GBA1MAPTKDM4EHSD17B10ALDH1A1
SCHEMBL17478898 0.89 MCHR1 (0.45) GBA1MAPTKDM4EHSD17B10ALDH1A1
SCHEMBL17479076 0.89 GBA1 (0.42) GBA1MAPTKDM4EHSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106573915-B Compounds active against bromodomains 纽韦卢森公司 2020-12-25 CN claimed
US-10752640-B2 Compounds active towards bromodomains NUEVOLUTION A/S (DK) 2020-08-25 US claimed
US-20170349607-A1 COMPOUNDS ACTIVE TOWARDS BROMODOMAINS NUEVOLUTION A/S (DK) 2017-12-07 US claimed
EP-3174868-A1 COMPOUNDS ACTIVE TOWARDS BROMODOMAINS Nuevolution A/S (DK) 2017-06-07 EP claimed
WO-2016016316-A1 COMPOUNDS ACTIVE TOWARDS BROMODOMAINS NUEVOLUTION A/S (DK) 2016-02-04 WO claimed
US-10752640-B2 Compounds active towards bromodomains NUEVOLUTION A/S (DK) 2020-08-25 US disclosed
US-20170349607-A1 COMPOUNDS ACTIVE TOWARDS BROMODOMAINS NUEVOLUTION A/S (DK) 2017-12-07 US disclosed
US-20170349607-A1 COMPOUNDS ACTIVE TOWARDS BROMODOMAINS NUEVOLUTION A/S (DK) 2017-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170349607-A1 COMPOUNDS ACTIVE TOWARDS BROMODOMAINS BRD4, BRD3, BRDT GBA1 1736/4885MAPT 575/4885KDM4E 626/4885
US-10752640-B2 Compounds active towards bromodomains BRD4, BRD3, BRDT GBA1 1736/4885MAPT 575/4885KDM4E 626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.